A CRISPR Platform for Targeted In Vivo Screens.

Maranda, Vincent; Zhang, Yue; Vizeacoumar, Frederick S; Freywald, Andrew; Vizeacoumar, Franco J

Maranda, Vincent; Zhang, Yue; Vizeacoumar, Frederick S; Freywald, Andrew; Vizeacoumar, Franco J.

Afiliación

Maranda V; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Zhang Y; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Vizeacoumar FS; Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Freywald A; Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon, Canada. andrew.freywald@usask.ca.
Vizeacoumar FJ; Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Canada. franco.vizeacoumar@usask.ca.

Methods Mol Biol ; 2614: 397-409, 2023.

Article en En | MEDLINE | ID: mdl-36587138

Asunto(s)

Sistemas CRISPR-Cas; Neoplasias; Humanos; Sistemas CRISPR-Cas/genética; Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas/genética; Genoma; Neoplasias/genética; Microambiente Tumoral/genética

Palabras clave

CRISPR-Cas9 screen; In vivo screen; Pooled screen; Synthetic lethality

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google